Mechanistic Insights into the Analgesic Action of Acetaminophen: Its Bioactive Metabolite Induces Peripheral Analgesia in Addition to Central Analgesia.

The molecular target and detailed mechanism of analgesic acetaminophen are still not fully understood despite being commonly used for many years. Through a literature search, the present study aimed to characterize the cyclooxygenase inhibitory properties of acetaminophen in comparison with non-steroidal anti-inflammatory drugs and to gain novel mechanistic insights into its analgesic action, especially focusing on the peripheral mechanisms. Comparative characterization indicated that acetaminophen is relatively selective for cyclooxygenase-2 but less potent to inhibit cyclooxygenase than non-steroidal anti-inflammatory drugs. This narrative review suggests that acetaminophen is very likely to be a prodrug, which is metabolically converted into bioactive N-arachidonoylphenolamine, AM404, by fatty acid amide hydrolase-mediated conjugation of acetaminophen metabolite 4-aminophenol with arachidonic acid not only in the central nervous system but also in the peripheral nervous system. It is considered that AM404 activates transient receptor potential vanilloid 1 and cannabinoid type 1 receptor distributed in the brain and spinal cord to induce analgesia centrally. In addition, it is speculated that AM404 produced in trigeminal ganglion neurons, dorsal root ganglion neurons, and primary sensory neurons inhibits nociceptive voltage-gated sodium channels through the local anesthetic binding site to suppress pain signaling and inhibits cyclooxygenase-2 to prevent the biosynthesis of prostaglandins responsible for nociception, thereby inducing peripheral analgesia. We propose the mechanistic hypothesis for the analgesic effects of acetaminophen to integrate central and peripheral action of its bioactive entity AM404, which should provide the pharmacological rationale for the use of acetaminophen to relieve postoperative and inflammatory pain and its application to multimodal analgesia.

Authors

Publication Details

Journal
PubMed
Published
2026-08-17
DOI
https://doi.org/10.1159/mpp/adpag006
Primary Topic
Inflammatory mediators and NSAID effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mechanistic Insights into the Analgesic Action of Acetaminophen: Its Bioactive Metabolite Induces Peripheral Analgesia in Addition to Central Analgesia.

Maki Mizogami, Yoshiaki Takai, Hironori Tsuchiya
PubMed
Inflammatory mediators and NSAID effects
article

Mechanistic Insights into the Analgesic Action of Acetaminophen: Its Bioactive Metabolite Induces Peripheral Analgesia in Addition to Central Analgesia.

Maki Mizogami, Yoshiaki Takai, Hironori Tsuchiya
article en

Abstract

The molecular target and detailed mechanism of analgesic acetaminophen are still not fully understood despite being commonly used for many years. Through a literature search, the present study aimed to characterize the cyclooxygenase inhibitory properties of acetaminophen in comparison with non-steroidal anti-inflammatory drugs and to gain novel mechanistic insights into its analgesic action, especially focusing on the peripheral mechanisms. Comparative characterization indicated that acetaminophen is relatively selective for cyclooxygenase-2 but less potent to inhibit cyclooxygenase than non-steroidal anti-inflammatory drugs. This narrative review suggests that acetaminophen is very likely to be a prodrug, which is metabolically converted into bioactive N-arachidonoylphenolamine, AM404, by fatty acid amide hydrolase-mediated conjugation of acetaminophen metabolite 4-aminophenol with arachidonic acid not only in the central nervous system but also in the peripheral nervous system. It is considered that AM404 activates transient receptor potential vanilloid 1 and cannabinoid type 1 receptor distributed in the brain and spinal cord to induce analgesia centrally. In addition, it is speculated that AM404 produced in trigeminal ganglion neurons, dorsal root ganglion neurons, and primary sensory neurons inhibits nociceptive voltage-gated sodium channels through the local anesthetic binding site to suppress pain signaling and inhibits cyclooxygenase-2 to prevent the biosynthesis of prostaglandins responsible for nociception, thereby inducing peripheral analgesia. We propose the mechanistic hypothesis for the analgesic effects of acetaminophen to integrate central and peripheral action of its bioactive entity AM404, which should provide the pharmacological rationale for the use of acetaminophen to relieve postoperative and inflammatory pain and its application to multimodal analgesia.

PubMed
Good health and well-being
Openalex Percentile: Top 11%
Inflammatory mediators and NSAID effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.